Regeneron Pharmaceuticals has announced that the FDA has approved Eylea (aflibercept) injection for treatment of diabetic macular edema (DME) in the U.S. Eylea now joins Genentech’s Lucentis (ramabizumab) as a treatment for DME in addition to neovascular (wet) age-related macular degeneration and macular edema after central retinal vein occlusion. Aflibercept has also been approved for […]
Depression is a common risk for people who have lost their vision, but a new study shows that a new approach called “behavior activation” can cut the risk in half. Researchers from Wilmer Eye Institute, Sidney Kimmel Medical College, and Wills Eye Hospital have announced results from their Low Vision Depression Prevention Trial (VITAL), designed […]
by Dan Roberts Caregivers of older adults have understandable concerns about potential suicide when their loved ones begin talking about death. They may, however, be worrying unnecessarily. During those moments, three questions need to be considered: 1. Is the person depressed? 2. Is the person suicidal? 3. Is the person simply sharing personal thoughts? Risk […]
by Dan Roberts Ophthalmic nearsightedness (myopia) results from an abnormal elongation of the eyeball during the growing years. This extra “axial length” causes objects at a distance to appear out of focus, which can usually be corrected with prescription glasses. The physical aspects of extreme nearsightedness (hypermyopia), however, can lead to a type of uncorrectable […]